RTOG 1014: A Phase II study of repeat breast preserving surgery and 3D conformal partial breast re-irradiation (PBri) for local recurrence of breast cancer

Print this page

RTOG 1014: A Phase II study of repeat breast preserving surgery and 3D conformal partial breast re-irradiation (PBri) for local recurrence of breast cancer

The purpose of this study is to evaluate the tumor control and side effects of partial breast re-irradiation given after a lumpectomy. Patients who have had a lumpectomy and are eligible for this trial will receive highly conformal three dimensional conformal radiation therapy (3D-CRT) to treat only the area in the breast where the lumpectomy was performed. 3D-CRT tries to lower the amount of radiation that normal tissues receive, while still delivering the desired amount of radiation to the cancer and to areas that the study doctor thinks may have cancer cells.

Protocol Number041005
Principal InvestigatorMolly Gabel
PhasePhase II
ScopeNational
Applicable Disease SitesBreast - Female
Therapies InvolvedRadiotherapy
Participating InstitutionsThe Cancer Institute of New Jersey

For further information on this clinical trial, please contact us at 732-235-8675 or cinjclinicaltrials@umdnj.edu.